Increasing Volume but Decreasing Mortality of Hospitalized Hepatitis C Patients in the United States, 2005 to 2011

Journal of Clinical Gastroenterology

Volumn 49, Issue 7, 2015, Pages 620-627

  Luo, Ruihong ^a   Greenberg, Alan ^b   Stone, Christian D ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b University Medical Center of Southern Nevada   (United States)

Author keywords

epidemiology; NIS analysis; outcomes; risk factors

Indexed keywords

ACUTE LIVER FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; ECONOMIC ASPECT; FEMALE; HEALTH CARE UTILIZATION; HEPATITIS C; HOSPITAL CHARGE; HOSPITAL SERVICE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEPTICEMIA; SURVIVAL; UNITED STATES; ACUTE KIDNEY INJURY; COMPLICATION; ECONOMICS; EPIDEMIOLOGY; HOSPITAL MORTALITY; LIVER CIRRHOSIS; MIDDLE AGED; ODDS RATIO; RESPIRATORY INSUFFICIENCY; SEPSIS; TRENDS; UTILIZATION REVIEW;

ACUTE KIDNEY INJURY; FEMALE; HEPATITIS C; HOSPITAL CHARGES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; UNITED STATES; UTILIZATION REVIEW;

EID: 84937718168     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000216     Document Type: Article

References (34)

1. Wasley A, Grytdal S, Gallagher K. Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis-United States, 2006. MMWR Surveill Summ. 2008;57:1-24.
2. National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of Viral Hepatitis. Viral hepatitis surveillance, United States, 2010. Available at: http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/index.htm. Accessed January 29, 2014.
3. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-714.
4. Verna EC, Brown RS Jr. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2006;10:919-940.
5. Singal AG, Volk ML, Jensen D, et al. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol. 2010;8:280-288.
6. Morgan TR, Ghany MG, Kim HY, et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology. 2010;52:833-844.
7. Nguyen GC, Segev DL, Thuluvath PJ. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol. 2007;5:1092-1099.
8. Myers RP, Quan H, Hubbard JN, et al. Predicting in-hospital Mortality in patients with cirrhosis: results differ across risk adjustment methods. Hepatology. 2009;49:568-577.
9. Agency for Healthcare Research and Quality (AHRQ). HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2011. Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed January 29, 2014.
10. Agency for Healthcare Research and Quality (AHRQ). Nationwide Inpatient Sample (NIS)-Description of Data Elements. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2014. Available at: http://www.hcupus. ahrq.gov/db/nation/nis/nisdbdocumentation.jsp. Accessed January 29, 2014.
11. Agency for Healthcare Research and Quality (AHRQ). Nationwide Inpatient Sample (NIS)-HCUP Coding Practices. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2008. Available at: http://www.hcup-us.ahrq.gov/db/coding.jsp. Accessed January 29, 2014.
12. Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997;26:62S-65S.
13. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61:1-32.
14. Centers for Disease Control and Prevention (CDC). Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 2011;60:537-541.
15. Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8:851-858.
16. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant. 2005;5:307-313.
17. Morando F, Maresio G, Piano S, et al. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013;59:257-264.
18. Manos MM, Darbinian J, Rubin J, et al. The effect of hepatitis C treatment response on medical costs: a longitudinal analysis in an integrated care setting. J Manag Care Pharm. 2013;19:438-447.
19. Kramer JR, Giordano TP, Souchek J, et al. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C. Am J Gastroenterol. 2005;100:56-63.
20. Kim AY, Chung RT. Coinfection with HIV-1 and HCV-a one-two punch. Gastroenterology. 2009;137:795-814.
21. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999;30:1054-1058.
22. Monga HK, Rodriguez-Barradas MC, Breaux K, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;33:240-247.
23. Kirk GD, Mehta SH, Astemborski J, et al. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study. Ann Intern Med. 2013;158:658-666.
24. Fierer DS, Dieterich DT, Fiel MI, et al. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIVinfected men after primary hepatitis C virus infection. Clin Infect Dis. 2013;56:1038-1043.
25. Kramer JR, Giordano TP, Souchek J, et al. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol. 2005;42:309-314.
26. Salmon-Ceron D, Rosenthal E, Lewden C, et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French National Mortalite 2005 study. J Hepatol. 2009;50:736-745.
27. Rosenthal E, Salmon-Ceron D, Lewden C, et al. Liver related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19). HIV Med. 2009;10:282-289.
28. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33: 562-569.
29. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992;103:317-322.
30. Dickson RC, Caldwell SH, Ishitani MB, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation. 1996;61:701-705.
31. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl. 2002;8:S14-S18.
32. Yilmaz N, Shiffman ML, Stravitz RT, et al. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transpl. 2007;13:975-983.
33. Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol. 2013;19: 105-115.
34. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42: S100-S107.